381285- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient fluorouracil (ATC code: D11AF05).

World Biggest Tenders Source

This tender with title 381285- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient fluorouracil (ATC code: D11AF05). has been published on Bidding Source portal dated 17 Jun 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

381285- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient fluorouracil (ATC code: D11AF05).

Tender Type :

Invitation for Bids

Reference No. :

381285

Country :

Germany

Publish Date :

17 Jun 2025

Closing Date :

27 May 2027

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

382655- Germany – Pharmaceutical products – 1/DLII6/PM020 - Arzneimittel - Virostatika Germany 365213-Awarded - Germany – Pharmaceutical products – Award of sterile saline syringes as of 01.07.2025 Germany 359051-Awarded - Germany – Pharmaceutical products – Minirin Parenteral 4µg Inj.lösung Germany 350661- Germany – Pharmaceutical products – 3. Biologics tender Germany 351177-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130c Paragraph 1 SGB V between IKK classic and Abacus Medicine A/S for Skyrizi(R) -- <b>Contract Value: 1,00 EUR</b> Germany 344615- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the option of concluding the agreement within the framework of the so-called open house procedure. Germany 349800- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130 a Paragraph 8 SGB V from 1 July 2025 Germany 336062- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-17 -Agalsidase beta Germany 330350- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the Social Code Book V (SGB V) through an open-house model for the active ingredient fusidic acid/betamethasone (ATC code according to WHO: D07CC01) Germany 332579- Germany – Pharmaceutical products – Open House Original Discount Agreements 2025-17 - Beclometasone, Formoterol, Glycopyrronium (active ingredient combination) ATC: R03AL09 Germany

381285- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient fluorouracil (ATC code: D11AF05).

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com